Gilead Sciences (GILD) Shares Bounce Higher Following HCV/NASH News

October 20, 2016 11:45 AM EDT

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Gilead Sciences (NASDAQ: GILD) shares are traveling higher following an initial pop on NASH and HCV development news. The stock is now up around 1 percent.

For the latest on Gilead, click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Trader Talk

Add Your Comment